Healthcare
Sunday, April 10, 2016
BRIEF-OSE Pharma: Hungary opens recruitment in global pivotal phase 3 trial of the immunotherapy Tedopi
* Fifth country opens recruitment in the global pivotal phase 3 trial of the immunotherapy Tedopi with initiation in Hungary
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment